Main Library
AI risk alerts, new biomarkers and expanded screening are landing on primary care physicians without added time or staff. Shifting outreach, testing coordination and closed-loop referrals to partners can help practices close the gap.
Medicine has learned to identify risk and diagnose diseases faster than health care has learned to manage them. Before walking into the exam room for an otherwise routine visit, a primary care physician may see alerts and recommendations for any number of issues that need to be addressed: colorectal cancer screening, kidney disease evaluation, quality measures and perhaps a new AI-generated alert suggesting elevated risk for Type 1 diabetes or atrial fibrillation.
Each recommendation is clinically appropriate and tied to positive clinical outcomes and a tangible revenue opportunity. Together, they expose a growing gap between scientific progress and health care’s ability to deliver it.
For decades, health care has worked hard to diagnose diseases earlier. Today, advances in biomarkers, predictive analytics, genomics and precision medicine are making that goal increasingly achievable across nearly every specialty. Precision has concentrated at the ends of care, though, keeping healthy people healthy and personalizing treatment once disease is confirmed. The middle, where disease is progressing quietly, has drawn far less investment.